Naturally occurring compounds as pancreatic cancer therapeutics

about

Naturally occurring compounds as pancreatic cancer therapeutics

Item

http://www.wikidata.org/entity/Q59128443

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Naturally occurring compounds as pancreatic cancer therapeutics

@en

Naturally occurring compounds as pancreatic cancer therapeutics

@nl

type

Item

label

Naturally occurring compounds as pancreatic cancer therapeutics

@en

Naturally occurring compounds as pancreatic cancer therapeutics

@nl

prefLabel

Naturally occurring compounds as pancreatic cancer therapeutics

@en

Naturally occurring compounds as pancreatic cancer therapeutics

@nl

P1476

Naturally occurring compounds as pancreatic cancer therapeutics

@en

P2093

Erin Wildermuth

http://www.w3.org/2001/XMLSchema#string

Ines Lohse

http://www.w3.org/2001/XMLSchema#string

Shaun P Brothers

http://www.w3.org/2001/XMLSchema#string

P2860

The mTOR signalling pathway in human cancer

Targeting mTOR in Pancreatic Ductal Adenocarcinoma

Pancreatic cancer surgery: past, present, and future

Bevacizumab in Combination with Taxane versus Non-Taxane Containing Regimens for Advanced/Metastatic Nonsquamous Non-Small-Cell Lung Cancer: A Systematic Review

Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans

mTOR kinase inhibitors as potential cancer therapeutic drugs

Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells

A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns

Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes.

nab-Paclitaxel plus gemcitabine for metastatic pancreatic cancer: a subgroup analysis of the Western European cohort of the MPACT trial

P304

35448-35457

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.26234

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-10-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30459936

http://www.w3.org/2001/XMLSchema#string

P932

6226042

http://www.w3.org/2001/XMLSchema#string